Apimeds Pharmaceuticals US, Inc. - 8-K Filing

Apimeds Pharmaceuticals US appoints Sungjoon Chae to board and amends settlement agreement with Inscobee Parties (Items: 1.01 Entry into a Material Definitive Agreement, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $APUS

Read the full article at SEC EDGAR

More Regulatory news